tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Denali Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
The FlyDenali Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
7d ago
DNLI
Denali Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
PremiumThe Fly
Denali Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald
7d ago
DNLI
Denali Therapeutics Begins BLA Submission for Tividenofusp Alfa
PremiumCompany Announcements
Denali Therapeutics Begins BLA Submission for Tividenofusp Alfa
15d ago
8K
DNLI
Denali initiates BLA filing for accelerated approval of tividenofusp alfa
PremiumThe Fly
Denali initiates BLA filing for accelerated approval of tividenofusp alfa
15d ago
DNLI
Denali Therapeutics price target lowered to $28 from $30 at BofA
PremiumThe Fly
Denali Therapeutics price target lowered to $28 from $30 at BofA
1M ago
DNLI
Denali Therapeutics assumed with an Overweight at Morgan Stanley
PremiumThe FlyDenali Therapeutics assumed with an Overweight at Morgan Stanley
1M ago
DNLI
Denali Therapeutics: Promising Growth Prospects Despite Recent Setbacks
Premium
Ratings
Denali Therapeutics: Promising Growth Prospects Despite Recent Setbacks
1M ago
DNLI
Denali Therapeutics Discontinues DNL343 ALS Trial
Premium
Company Announcements
Denali Therapeutics Discontinues DNL343 ALS Trial
1M ago
8K
DNLI
Denali Therapeutics discontinues active treatment extension in eIF2B Regimen G
PremiumThe Fly
Denali Therapeutics discontinues active treatment extension in eIF2B Regimen G
1M ago
DNLI
Denali Therapeutics price target lowered to $35 from $38 at B. Riley
PremiumThe Fly
Denali Therapeutics price target lowered to $35 from $38 at B. Riley
1M ago
DNLI
Denali Therapeutics price target lowered to $42 from $50 at Oppenheimer
PremiumThe Fly
Denali Therapeutics price target lowered to $42 from $50 at Oppenheimer
2M ago
DNLI
Denali Therapeutics: Promising Drug Pipeline and Financial Stability Support Buy Rating
PremiumRatings
Denali Therapeutics: Promising Drug Pipeline and Financial Stability Support Buy Rating
2M ago
DNLI
Denali Therapeutics price target lowered to $32 from $33 at Wedbush
PremiumThe FlyDenali Therapeutics price target lowered to $32 from $33 at Wedbush
2M ago
DNLI
Positive Outlook for Denali Therapeutics: Strategic Progress and Promising Developments Support Buy Rating
Premium
Ratings
Positive Outlook for Denali Therapeutics: Strategic Progress and Promising Developments Support Buy Rating
2M ago
DNLI
Denali Therapeutics: Promising ETV Platform and Strategic Advancements Justify Buy Rating
Premium
Ratings
Denali Therapeutics: Promising ETV Platform and Strategic Advancements Justify Buy Rating
2M ago
DNLI
Denali Therapeutics price target lowered to $80 from $87 at H.C. Wainwright
PremiumThe Fly
Denali Therapeutics price target lowered to $80 from $87 at H.C. Wainwright
2M ago
DNLI
Denali Therapeutics Reports 2024 Financial Results and Progress
PremiumCompany Announcements
Denali Therapeutics Reports 2024 Financial Results and Progress
2M ago
DNLI
Denali Therapeutics Signs New Equity Distribution Deal
PremiumCompany Announcements
Denali Therapeutics Signs New Equity Distribution Deal
2M ago
8K
DNLI
Denali Therapeutics reports Q4 EPS (67c), consensus (85c)
PremiumThe Fly
Denali Therapeutics reports Q4 EPS (67c), consensus (85c)
2M ago
DNLI
Denali Therapeutics files automatic mixed securities shelf
PremiumThe FlyDenali Therapeutics files automatic mixed securities shelf
2M ago
DNLI
Denali Therapeutics initiated with a Buy at Deutsche Bank
Premium
The Fly
Denali Therapeutics initiated with a Buy at Deutsche Bank
2M ago
DNLI
Denali Therapeutics announces primary analysis of Phase 1/2 study in MPS II
Premium
The Fly
Denali Therapeutics announces primary analysis of Phase 1/2 study in MPS II
2M ago
DNLI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >